Mnemo Therapeutics
Jean-Louis Labernardière has over 14 years of professional experience. Most recently, they have been working as the Lab Operations Manager at Mnemo Therapeutics since 2021. Prior to that, they were the Manager Recherche et Innovation at DBV Technologies SA (Fr) from 2018-2021. From 2007-2018, they were employed at Onxeo S.A., where they held the roles of Head of Laboratory, Coordinateur Pharmaco-oncologie in vitro, and Responsable biologie cellulaire et moléculaire. Before that, they were an Elève-Ingénieur at Institut Pasteur from 2006-2007.
Jean-Louis Labernardière began their education in 1998 when they enrolled in the Ecole Supérieure des Techniques de Biologie Appliquée and obtained a BTS Biochimiste. The following year, they continued their studies at the same school and earned a Certificat d'Etudes Spécialisées Technologiques in Recherche Biomédicale option Immunologie. In 2000, they moved to the Conservatoire National des Arts et Métiers, where they obtained an Ingénieur du CNAM in Génie Biologique in 2006.
Previous companies
This person is not in any offices
Mnemo Therapeutics
1 followers
Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a transatlantic team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.